EndorTech

Company Overview

Snapshot

Founded in June 2023 by Ronen Sasson, EndorTech operates with 1–10 employees. The company is currently in a Pre-Funding stage and ceased operations in June 2026.

Business overview

EndorTech is a Health Tech & Life Sciences company focused on developing a synthetic beta-endorphin aerosol platform for pain relief. The company's core technology involves a patented disruptive mechanism utilizing pure synthetic aerosoled beta-endorphin, a neuropeptide, to provide rapid pain relief without pills or injections. EndorTech aims to offer a natural alternative to opioid pain killers with no side effects, targeting the pharmaceutical and drug delivery markets.

Company Intelligence Q&A

What is EndorTech's primary focus?

EndorTech focuses on developing a synthetic beta-endorphin aerosol platform designed for pain relief, offering an alternative to traditional opioid pain medications.

When was EndorTech founded?

EndorTech was founded in June 2023.

Who is the founder of EndorTech?

Ronen Sasson is the Co-founder & CEO of EndorTech.

What is the current operational status of EndorTech?

EndorTech is currently non-active and ceased to operate in June 2026.

What is EndorTech's product stage?

EndorTech's products are in the Beta stage, including offerings like EndoRelief, EndoRecover, and EndoElevate.